Business Segments · Research and development expense

Medical Surgical — Research and development expense

Medtronic Medical Surgical — Research and development expense decreased by 3.9% to $174.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 6.1%, from $164.00M to $174.00M.

Analysis

StatementSegment
CategoryGrowth
SignalContext dependent
VolatilityStable
First reportedQ1 2023
Last reportedQ1 2026

How to read this metric

Higher spending indicates a focus on future growth and innovation, while lower spending may signal cost-cutting or a mature product cycle.

Detailed definition

Represents the costs incurred by the Medical Surgical segment for research, design, and development of new medical devic...

Peer comparison

Standard R&D expense reported by medical device peers like Stryker or Boston Scientific.

Metric ID: mdt_segment_medical_surgical_research_and_development_expense

Historical Data

11 periods
 Q1 '23Q2 '23Q3 '23Q4 '23Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$135.75M$135.75M$135.75M$135.75M$162.00M$171.00M$164.00M$185.00M$169.00M$181.00M$174.00M
QoQ Change+0.0%+0.0%+0.0%+19.3%+5.6%-4.1%+12.8%-8.6%+7.1%-3.9%
YoY Change+19.3%+26.0%+4.3%+5.8%+6.1%
Range$135.75M$185.00M
CAGR+10.4%
Avg YoY Growth+12.3%
Median YoY Growth+6.1%

Frequently Asked Questions

What is Medtronic's medical surgical — research and development expense?
Medtronic (MDT) reported medical surgical — research and development expense of $174.00M in Q1 2026.
How has Medtronic's medical surgical — research and development expense changed year-over-year?
Medtronic's medical surgical — research and development expense increased by 6.1% year-over-year, from $164.00M to $174.00M.
What does medical surgical — research and development expense mean?
The amount spent on researching and developing new products within the Medical Surgical business unit.